These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 1924637

  • 1. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.
    Callaway CW, Johnson MP, Gold LH, Nichols DE, Geyer MA.
    Psychopharmacology (Berl); 1991; 104(3):293-301. PubMed ID: 1924637
    [Abstract] [Full Text] [Related]

  • 2. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW, Wing LL, Geyer MA.
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [Abstract] [Full Text] [Related]

  • 3. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL, Callaway CW, Geyer MA.
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [Abstract] [Full Text] [Related]

  • 4. Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.
    Callaway CW, Geyer MA.
    Eur J Pharmacol; 1992 Apr 07; 214(1):45-51. PubMed ID: 1349861
    [Abstract] [Full Text] [Related]

  • 5. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
    Johnson MP, Conarty PF, Nichols DE.
    Eur J Pharmacol; 1991 Jul 23; 200(1):9-16. PubMed ID: 1685125
    [Abstract] [Full Text] [Related]

  • 6. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
    Berger UV, Gu XF, Azmitia EC.
    Eur J Pharmacol; 1992 May 14; 215(2-3):153-60. PubMed ID: 1356787
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Methysergide potentiates the hyperactivity produced by MDMA in rats.
    Gold LH, Koob GF.
    Pharmacol Biochem Behav; 1988 Mar 14; 29(3):645-8. PubMed ID: 2896363
    [Abstract] [Full Text] [Related]

  • 9. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI, Murray TK, Green AR.
    Br J Pharmacol; 1993 Mar 14; 108(3):583-9. PubMed ID: 7682129
    [Abstract] [Full Text] [Related]

  • 10. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
    Johnson MP, Nichols DE.
    Pharmacol Biochem Behav; 1989 May 14; 33(1):105-8. PubMed ID: 2476831
    [Abstract] [Full Text] [Related]

  • 11. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
    Nash JF, Brodkin J.
    J Pharmacol Exp Ther; 1991 Nov 14; 259(2):820-5. PubMed ID: 1682486
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
    Slikker W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR.
    Toxicol Appl Pharmacol; 1988 Jul 14; 94(3):448-57. PubMed ID: 2456631
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ, Robinson SE, Rosecrans JA.
    Eur J Pharmacol; 1987 Jun 19; 138(2):265-8. PubMed ID: 2887440
    [Abstract] [Full Text] [Related]

  • 16. Drug discrimination studies with MDMA and amphetamine.
    Oberlender R, Nichols DE.
    Psychopharmacology (Berl); 1988 Jun 19; 95(1):71-6. PubMed ID: 2898791
    [Abstract] [Full Text] [Related]

  • 17. A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.
    Gold LH, Hubner CB, Koob GF.
    Psychopharmacology (Berl); 1989 Jun 19; 99(1):40-7. PubMed ID: 2571175
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.
    Gazzara RA, Takeda H, Cho AK, Howard SG.
    Eur J Pharmacol; 1989 Sep 13; 168(2):209-17. PubMed ID: 2575036
    [Abstract] [Full Text] [Related]

  • 19. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD, Nichols DE, Yim GK.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2297-303. PubMed ID: 2886126
    [Abstract] [Full Text] [Related]

  • 20. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
    Stone DM, Stahl DC, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1986 Aug 22; 128(1-2):41-8. PubMed ID: 2875893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.